2017 DVMA Meetings:

  • Wednesday, April 19, 2017 – DVMA Spring Conference – The Modern Maturity Center
  • Wednesday, November 29, 2017 – DVMA Winter Conference – Dover Downs Conference Center


Spring Conference Information – April 19 @ The Modern Maturity Center


Michael Hickey, DVM, Diplomate, ACVIM (Cardiology)

Dr. Hickey earned a bachelor’s degree in biology from the University of Maryland-College Park in 2005, where a few excellent physiology courses got him interested in cardiology.   He received a DVM from the Virginia-Maryland Regional College of Veterinary Medicine in 2009.  He then completed a rotating internship at the Hope Center for Advanced Veterinary Medicine in Vienna.  In his spare time, he enjoys cooking and trying new restaurants with his wife, Katie, planning for future travel, following the Maryland Terps and DC United, and spending time with his 2 mixed breed dogs, Mia and Mosley.


Electrocardiography and Arrhythmia Diagnosis in Dogs and Cats

This session will review proper recording adn analysis of electrocardiograms in dogs and cats with a focus on identification and classification of arrhythmias.

Antiarrhythmic Drugs and Treatment of Arrhythmias in Dogs and Cats

This session will review the antiarrhythmic drugs used commonly in dogs and cats, and commonly used algorithms for the treatment of arrhythmias.


Karyn Bischoff DVM, MS, D.ABVT

Karyn Bischoff is a diplomate of the American Board of Veterinary Toxicology. A native Chicago girl, after graduating veterinary school from Illinois she completed a toxicology residency at Oklahoma State University. She spent the next year studying laboratory animal medicine and ecology at the University of Alaska, Fairbanks, then another year studying heavy metal interactions at an atomic level at Argonne National Laboratory and Illinois Institute of Technology. She has also completed a residency in anatomic pathology at the University of Florida. At the Cornell University and New York State Animal Health Diagnostic Center she has been involved in teaching veterinary students and working up a variety of toxicology cases involving companion animals, livestock, exotic pets, zoo animals, wildlife, and fish. Of particular interest, she has been involved in numerous lead poisoning cases in cattle and several high-profile pet food contamination cases. Karyn has developed an interest in the One Health philosophy and hopes to join Cornell’s new graduate program and eventually receive a Masters of Public Health. Meanwhile, she enjoys talking about toxicology and meeting veterinarians from different cultures around the world, which has inspired her to try, with limited success thus far, to learn a second language. When she’s not working or studying, she can sometimes be found in her beautiful 1850(ish) farm house communing with her long suffering horse, cats, chickens, dogs, and significant human.

Rodenticides & Regulations

The learning objectives of this session are to:

  • Understand the new EPA regulations concerning rodenticides
  • Understand how these regulations will affect practicing veterinarians.
  • Know common anticoagulant rodenticides.
  • Know other common types of rodenticides, MOA, clinical signs, treatment, and prognosis
    • Bromethalin
    • Cholecalciferol
    • Zinc phosphide
  • Know which is likely to expose the client and veterinary professional to toxic gas

Antidotes and ILE: A new treatment option for the poisoned patient

Synopsis: Intravascular administration of lipid emulsion (ILE) was first used in the 1990s by Guy Weinberg, MD to treat anesthetic overdose. This cost-effective technique has since been used clinically to treat human, canine, and equine patients exposed to moxidectin, ivermectin, pentobarbital, THC (cannabis), SSRIs, and other lipophilic compounds. We will go over current theories to explain how ILE works, uses of ILE, expected outcomes, and potential adverse effects.

The learning objectives of this session are to:

  • Review of treating the poisoned patient
    • ABCs
    • Antidotes
  • Intravenous lipid emulsion
    • What it is
    • How it might work
    • Current uses
    • Treatment protocol
    • Adverse effects

Robert M. Dyer VMD, PhD

Dr. Robert M. Dyer earned a BS degree in Animal Science from the University of Massachusetts (1971), a VMD degree from the University of Pennsylvania School of Veterinary Medicine (1975) and a Doctorate in Comparative Medical Sciences from the University of Pennsylvania (1981). He completed a large animal internship and residency at Cornell in 1979; completed a second large animal residency at Michigan State University in 1983. Dr. Dyer joined the faculty at New Bolton Center, University of Pennsylvania, as a lecturer in large animal medicine in 1983. He then served as Assistant Professor (1992-1993) and then Associate Professor (1993-1998) of Production Management Medicine at the Virginia-Maryland Regional College of Veterinary Medicine. In 1998, Dr. Dyer assumed his current position, Associate Professor of Animal Sciences at the University of Delaware, College of Agriculture and Natural Resources, Department of Animal and Food Sciences.

Dr. Dyer has published 35 scientific journal articles, 36 abstracts, and co-authored five text books. His current research interest centers on how metabolic inflammation and endotoxemia trigger disease problems across a number of anatomic systems in animals.

Nutrient overburdened animals: Adipose depot-Immune System Interfaces Leading to Metabolic Endotoxemia and Metabolic Inflammation.

Overweight and obesity problems are growing issues that affect most if not all of the US domestic animal population. Health complications associated with nutrient overburdened animals include metabolic syndromes with the associated dyslipidemia, fatty liver degeneration, and type 2 diabetes. Contemporary findings indicate most if not all the health events surrounding the overweight condition stem from a subtle, unresolved and sustained chronic inflammatory response. Normally, immune balance across tissues favors a quiet anti-inflammatory state that minimizes tissue injury due to inflammation. Expansion of the adipose depot however, tips the normal homeostatic state of immune balance away from a quiescent anti- inflammatory phenotype and more toward a pro-inflammatory phenotype. Continued expansion of the adipose depot sustains triggers of the inflammatory response leading to unresolvable states of metabolic inflammatory disease (metainflammation). Cellular components of both the innate and adoptive immune response within the adipose depots and the gastrointestinal wall can function to protect against or contribute to the metabolic inflammatory state. Indeed, diet factors induce shifts in gastrointestinal microbial community composition and trigger mucosal immune and inflammatory events that can erode permeability barrier functions of the mucosa. Translocation of microbial elements across a leaky intestine drive gastrointestinal as well as systemic immunological events that disturb homeostasis and immunity (metabolic endotoxemia) across a number of biologic systems and neural networks. Topics discussed include events underpinning the pathogenesis of metabolic endotoxemia and metabolic inflammation. The objective is to show how diet and nutritional events drive microbial and immunologic interactions that erode health across a number of anatomic systems.

Specific Topics Covered:

  • Hour 1: Regulatory Mechanisms in Immunity and Inflammation: Innate and Adoptive Immune Responses in the Adipose and Gastrointestinal Systems
  • Hour 2: Metabolic Endotoxemia: Gastrointestinal Contributions to Systemic Inflammatory Disorders
  • Hour 3: Metabolic Inflammation: Adipose Depot Expansion in Health and Disease